Patient Guide: Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 383 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05980949
Status: 🟢 Enrolling Now
Condition: Psychosis Associated With Alzheimer's Disease
Phase: PHASE3

Where You Can Participate

This study is available at 383 locations across the country.

Top locations include:
  • • Homewood, Alabama
  • • Chandler, Arizona
  • • Chandler, Arizona
  • • And 380 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) - Join Clinical Trial NCTNCT05980949

How to Join This Clinical Trial - NCTNCT05980949

Learn how to participate in this PHASE3 trial studying an investigational therapy for Psychosis Associated With Alzheimer's Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Psychosis Associated With Alzheimer's Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Psychosis Associated With Alzheimer's Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05980949 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 383 locations. Find a study site near you:

Clinical Research Site

Homewood, Alabama 35209-6809 - United States

Status: WITHDRAWN

Clinical Research Site

Chandler, Arizona 85224-6231 - United States

Status: WITHDRAWN

Clinical Research Site

Chandler, Arizona 85224-6231 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Chandler, Arizona 85286 - United States

Status: WITHDRAWN

Clinical Research Site

Phoenix, Arizona 85006-2528 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Phoenix, Arizona 85012-2836 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Scottsdale, Arizona 85260-6742 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Anaheim, California 92805-5854 - United States

Status: RECRUITING

Clinical Research Site

Costa Mesa, California 92626 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Encino, California 91316 - United States

Status: WITHDRAWN

And 373 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Psychosis Associated With Alzheimer's Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships